KONTAN.CO.ID - MADRID. Spain's medicines agency authorised the launch of late-stage trials of Johnson & Johnson's COVID-19 vaccine on Wednesday as the race to develop successful vaccines intensifies. The Phase III trial of the two-dose vaccination will be carried out in nine hospitals throughout Spain on volunteers both with and without previous health conditions, the AEMPS agency said in a statement. J&J started mid-stage phase II trials in Spain and other countries in September and launched a late-stage trial in Britain on Monday.
Spain authorises Phase III trial of Johnson & Johnson COVID-19 vaccine
KONTAN.CO.ID - MADRID. Spain's medicines agency authorised the launch of late-stage trials of Johnson & Johnson's COVID-19 vaccine on Wednesday as the race to develop successful vaccines intensifies. The Phase III trial of the two-dose vaccination will be carried out in nine hospitals throughout Spain on volunteers both with and without previous health conditions, the AEMPS agency said in a statement. J&J started mid-stage phase II trials in Spain and other countries in September and launched a late-stage trial in Britain on Monday.